INVA Company Profile and Key Details

Q: Who are the executives of INVA?

Mr. Pavel Raifeld C.F.A.Chief Executive OfficerMs. Marianne Zhen CPAChief Accounting Officer & Sec.

NASDAQ : INVA

Innoviva

$22.65

-0.34-1.48%

At Close 4:00 PM

63.81

B+ESG ScoreESG Rating

Profile Key Stats Analyst Ratings Ownership Ratios Financials Dividend & splits Sentiment Forecast

Price Chart

Stock Price Today

Innoviva, Inc. (INVA) stock declined over -1.48%, trading at $22.65 on NASDAQ, down from the previous close of $22.99. The stock opened at $23.03, fluctuating between $22.64 and $23.29 in the recent session.

Stock Snapshot

22.99

Prev. Close

1.46B

Market Cap

22.64

Day Low

6.86

P/E Ratio

3.3

EPS (TTM)

2.21

Cash Flow per Share

23.03

Open

64.34M

Number of Shares

23.285

Day High

91.48%

Free Float in %

10.59

Book Value

578.49K

Volume

Relevant Articles

SEC Fillings

Current Report (8-k)

Filing Date	Accepted Date

Annual Report (10-k)

Filing Date	Accepted Date

Stock Price History Chart

Date	Open	High	Low	Close	Volume
May 05, 2026	23.03	23.29	22.64	22.65	620.3K
May 04, 2026	22.94	23.43	22.86	22.99	458.7K
Apr 30, 2026	23.05	23.35	22.97	22.99	389.18K
Apr 29, 2026	23.38	23.38	22.95	23.05	564.18K
Apr 28, 2026	23.50	23.88	23.45	23.69	501.49K
Apr 27, 2026	23.93	23.93	23.19	23.36	541.17K
Apr 23, 2026	23.70	23.93	23.32	23.48	387.06K
Apr 22, 2026	23.75	23.82	23.33	23.50	448.55K
Apr 21, 2026	23.93	23.95	23.33	23.61	536.22K
Apr 20, 2026	24.20	24.45	23.81	23.92	590.03K
Apr 17, 2026	23.87	24.29	23.63	24.24	682.85K
Apr 16, 2026	23.77	23.98	23.28	23.60	757.13K
Apr 14, 2026	23.98	24.45	23.94	24.19	581.69K
Apr 13, 2026	23.80	23.99	23.39	23.97	548.58K
Apr 10, 2026	24.30	24.41	23.51	23.76	857.04K
Apr 09, 2026	23.60	24.21	23.55	24.20	657.66K
Apr 08, 2026	23.55	23.89	23.21	23.62	635.07K
Apr 07, 2026	22.95	23.39	22.75	23.28	531.26K
Apr 06, 2026	22.90	23.15	22.76	23.02	449.81K
Apr 02, 2026	23.21	23.37	22.91	22.99	595.08K

Contact Details

Burlingame, CA 94010

United States

https://www.inva.com 650 238 9600

About Company

Innoviva, Inc. engages in the development and commercialization of pharmaceuticals in the United States and internationally. Its products include RELVAR/BREO ELLIPTA, a once-daily combination medicine consisting of a LABA, vilanterol (VI), an inhaled corticosteroid (ICS), and fluticasone furoate; ANORO ELLIPTA, a once-daily medicine combining a long-acting muscarinic antagonist (LAMA), umeclidinium bromide (UMEC), with a LABA, and VI; and TRELEGY ELLIPTA, a once-daily combination medicine consisting of an ICS, LAMA, and LABA. Innoviva, Inc. has a strategic partnership with Sarissa Capital Management LP. The company has long-acting beta2 agonist (LABA) collaboration agreement with Glaxo Group Limited to develop and commercialize once-daily products for the treatment of chronic obstructive pulmonary disease and asthma. The company was formerly known as Theravance, Inc. and changed its name to Innoviva, Inc. in January 2016. Innoviva, Inc. was incorporated in 1996 and is headquartered in Burlingame, California.

Stock Peers

ARGX

-16.39-2.02%

argenx SE$794.70 REGN

-6.94-0.98%

Regeneron Pharmaceuticals, Inc.$702.27 UTHR

-9.02-1.55%

United Therapeutics Corporation$572.20 MDGL

-16.19-3.12%

Madrigal Pharmaceuticals, Inc.$502.47 VRTX

-5.49-1.28%

Vertex Pharmaceuticals Incorporated$424.36 PRAX

-4.31-1.28%

Praxis Precision Medicines, Inc.$333.30 KRTX

0.09+0.03%

Karuna Therapeutics, Inc.$329.83 ALNY

3.185+1.07%

Alnylam Pharmaceuticals, Inc.$301.11 KRYS

-2.38-0.83%

Krystal Biotech, Inc.$284.57 LGND

3.94+1.73%

Ligand Pharmaceuticals Incorporated$232.30

Frequently Asked Questions

What is the current Innoviva, Inc. (INVA) stock price?

Innoviva, Inc. (NASDAQ: INVA) stock price is $22.65 in the last trading session. During the trading session, INVA stock reached the peak price of $23.29 while $22.64 was the lowest point it dropped to. The percentage change in INVA stock occurred in the recent session was -1.48% while the dollar amount for the price change in INVA stock was - $0.34.

INVA's industry and sector of operation?

The NASDAQ listed INVA is part of Biotechnology industry that operates in the broader Healthcare sector. Innoviva, Inc. designs, manufactures, and markets smartphones, personal computers, tablets, wearables, and accessories worldwide.

Who are the executives of INVA?

Mr. Pavel Raifeld C.F.A.
Chief Executive Officer
Ms. Marianne Zhen CPA
Chief Accounting Officer & Sec.

How INVA did perform over past 52-week?

INVA's closing price is 37.11% higher than its 52-week low of $16.52 where as its distance from 52-week high of $25.15 is -9.94%.

How many employees does INVA have?

Number of INVA employees currently stands at 127.

Link for INVA official website?

Official Website of INVA is: https://www.inva.com

How do I contact INVA?

INVA could be contacted at phone 650 238 9600 and can also be accessed through its website. INVA operates from 1350 Old Bayshore Highway, Burlingame, CA 94010, United States.

How many shares of INVA are traded daily?

INVA stock volume for the day was 578.49K shares. The average number of INVA shares traded daily for last 3 months was 728.74K.

What is the market cap of INVA currently?

The market value of INVA currently stands at $1.46B with its latest stock price at $22.65 and 64.34M of its shares outstanding.

Stocks Telegraph provides information and tools designed to assist investors and Wall Street players. A major goal is to offer financiers comprehensive information that will help them gain insight into investing.

Stocks Telegraph does not provide any advice or recommendations for buying or selling stocks, securities, or other financial products. Information contained on this website is for informational purposes only and should not be construed as professional financial, investment or other advice. Stocks Telegraph is not liable for any loss or damage that may occur as a result of reliance on this data.

Employees	127
Beta	0.4
Sales or Revenue	$324.26M
5Y Sales Change%	0.833%
Fiscal Year Ends	December
Sector	Healthcare
Industry	Biotechnology

Employees	127
Beta	0.4
Sales or Revenue	$324.26M
5Y Sales Change%	0.833%
Fiscal Year Ends	December
Sector	Healthcare
Industry	Biotechnology

INVA Company Profile and Key Details

Innoviva

Price Chart

Stock Price Today

Stock Snapshot

Relevant Articles

SEC Fillings

Current Report (8-k)

Annual Report (10-k)

Stock Price History Chart

Contact Details

About Company

Company Information

Stock Peers

Frequently Asked Questions

Price Chart

Stock Price Today

Stock Snapshot

Relevant Articles

SEC Fillings

Current Report (8-k)

Annual Report (10-k)

Stock Price History Chart

Contact Details

About Company

Company Information

Stock Peers

Company Overview

Technical Performance

Valuation Metrics

Dividend & Fair Value

Earnings & Analyst Outlook

Shareholding & Insider Activity

Financial & Profitability Overview

Quarterly Financial Highlights

Price Forecast & Outlook

Key Takeaways

Frequently Asked Questions

Technical Performance

Shareholding & Insider Activity

Financial & Profitability Overview

Quarterly Financial Highlights

Earnings & Analyst Outlook

Dividend & Fair Value

Company Overview

Price Forecast & Outlook

Key Takeaways

Valuation Metrics